Cemiplimab for Cisplatin Resistant Metastatic Penile Cancer
We report on a 75-year old man who presented with metastatic, squamous-cell carcinoma (SCC) of the penis whose disease had progressed after radiotherapy (RT) and cisplatin-based chemotherapy (CT). A strong PD-L1 expression as well as a CDKN2A mutation was documented, and he was given cemiplimab ever...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Karger Publishers
2021-06-01
|
| Colección: | Case Reports in Oncology |
| Materias: | |
| Acceso en línea: | https://www.karger.com/Article/FullText/517008 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|